Metallothioneins (MTs) are a class of low molecular weight and cysteine-rich metal binding proteins present in all the branches of the tree of life. MTs efficiently bind with high affinity several essential and toxic divalent and monovalent transition metals by forming characteristic polynuclear metalthiolate clusters within their structure. MTs fulfil multiple biological functions related to their metal binding properties, with essential roles in both Zn(II) and Cu(I) homeostasis as well as metal detoxification. Depending on the organism considered, the primary sequence, and the specific physiological and The presence of nonsulfur coordination residues (e.g., histidine) in some members of the superfamily, such as bacterial and plant MTs, has broken the dogma of the exclusive metal coordination by cysteine thiolate residues in MTs. According to Binz and K€ agi (2), MTs are classified into 15 families based on taxonomic parameters and the patterns of distribution of Cys residues in their sequence. The recognized fundamental functions of MTs arise from their capabilities to bind transition metals with high affinity, and their primary biological roles include homeostasis of essential trace metals zinc and copper, and sequestration and protection from environmental toxic metals such as cadmium, mercury, and lead (1). In addition, in light of the reactivity of the metal-coordinating thiolate ligands, MTs play fundamental roles in protection against oxidative stress including reactive oxygen and nitrogen species and other free radicals (1,3-5). However, additional specific MT functions arise from specific biological needs and complexity of the organisms in which they are expressed. Since 60 years from their discovery, it emerged that metallothoineins indeed possess complex pleiotropic functions. This is exemplified by the better-studied mammalian MTs for which additional specialized roles in adaptation to stress, protection against brain injury, regulation of neuronal outgrowth, antiapoptotic effects, and reactivity and inactivation of metal-based chemotherapeutics leading to resistance have been demonstrated (4).As a result of the high number of thiolate coordinating residues in MTs and the lack of defined three-dimensional (3D) structures in the metal depleted apo forms, MTs can bind a number of different monovalent and divalent metals both in vitro and in vivo. The affinity of the metal ions for the binding